August 14, 2012 — The U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Stryker Neurovascular’s Trevo Pro Retriever, indicated for the removal of blood clots. It uses Stentriever technology to optimized clot integration and retrieval in patients experiencing acute ischemic stroke.

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical operations from the Crown Point, Ind. facility to its Lubbock, Texas site.

Biosense Webster Inc. launched the new Carto 3 MEM (Multi-Electrode Mapping) Version in the United States. It is the latest advancement on the Carto 3 system platform.

August 14, 2012 — The U.S. Food and Drug Administration (FDA) is hosting a public workshop that examines use of absorbable materials in implantable devices for endovascular therapies such as fully absorbable cardiovascular stents, where the stent platform degrades, as well as absorbable coatings.

McKesson released its Cardiology 13.0 system, which offers a single database solution for cardiac and peripheral catheterization, hemodynamic monitoring, electrophysiology (EP), echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG), ECG stress and Holter management. Data entered at any point-of-care flows into the electronic health record (EHR) without the need for potentially cumbersome interfaces or redundant documentation.  This latest release is designed to boost clinical efficiencies and reduce operational costs. 

August 13, 2012 — Analog Devices Inc. (ADI) has introduced a low-power, single-lead, heart rate monitor analog front end (AFE) for a wide range of vital sign monitoring applications. The AD8232 AFE is 50 percent smaller and uses up to 20 percent less power than other solutions.


August 13, 2012 — Providers are increasingly focused on using interventional labs in a hybrid operating room (OR) environment, but better support and training are needed to ensure success in this evolution of technology, suggests some of the findings in a recent KLAS study, “Interventional X-ray 2012: A Continuing Evolution.”

August 13, 2012 — To improve magnetic resonance (MR) exam efficiency and image quality, Toshiba America Medical Systems Inc. has received U.S. Food and Drug Administration (FDA) clearance for its high-density 16-element flexible coil system, developed in partnership with NeoCoil. The new coil system makes it easier for clinicians to complete high-quality exams and improve diagnostic efficiency.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now